GENinCode (LON:GENI) Stock Price Down 10.8% – Here’s What Happened

Shares of GENinCode Plc (LON:GENI) were down 10.8% during trading on Wednesday. The stock traded as low as GBX 0.55 and last traded at GBX 0.58. Approximately 3,466,466 shares were traded during trading, a decline of 27% from the average session volume of 4,753,782 shares. The stock had previously closed at GBX 0.65.

GENinCode Stock Down 10.8%

The business’s fifty day simple moving average is GBX 0.79 and its two-hundred day simple moving average is GBX 0.99. The company has a market cap of £4.37 million, a PE ratio of -0.46 and a beta of 0.59. The company has a debt-to-equity ratio of 4.75, a current ratio of 2.22 and a quick ratio of 15.88.

GENinCode (LON:GENI) last posted its earnings results on Tuesday, September 29th. The company reported GBX (0.38) earnings per share (EPS) for the quarter. GENinCode had a negative return on equity of 481.34% and a negative net margin of 202.42%. On average, analysts predict that GENinCode Plc will post -7.13 earnings per share for the current year.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.